Table of Content - Skin Cancer Drugs Market

N/A

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snippet, By Drug Type
  - Market Snippet, By Cancer Type
  - Market Snippet, By Route of Administration
  - Market Snippet, By Distribution Channel
  - Market Snippet, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Increasing incidence of skin cancers
  - High costs of targeted therapies
  - Combination therapies
- Key Highlights
- Regulatory Scenario
- Recent Trends
- Product Launches/Approvals
- PEST Analysis
- PORTER’s Analysis
- Mergers, Acquisitions, and Collaborations
Global Skin Cancer Drugs Market – Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
Global Skin Cancer Drugs Market, By Drug Type, 2018-2030, (US$ Bn)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2019 – 2030
  - Segment Trends
- Chemotherapy Drugs
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Targeted Therapy Drugs
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Immunotherapy Drugs
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Hormone Therapy Drugs
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Others (Photodynamic Therapy, Cryotherapy and Others)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Global Skin Cancer Drugs Market, By Cancer Type, 2018-2030, (US$ Bn)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2019 – 2030
  - Segment Trends
- Basal cell carcinoma
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Squamous cell carcinoma
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Melanoma
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Others (Kaposi's sarcoma, Mycosis fungoides and Others)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Global Skin Cancer Drugs Market, By Route of Administration, 2018-2030, (US$ Bn)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2019 – 2030
  - Segment Trends
- Topical
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Oral
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Injectable
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Others (Surgical procedures, radiation therapy and Others)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Global Skin Cancer Drugs Market, By Distribution Channel, 2018-2030, (US$ Bn)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2019 – 2030
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Global Skin Cancer Drugs Market, By Region, 2018-2030, (US$ Bn)
- Introduction
  - Market Share Analysis, By Sub-region, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, For Sub-region, 2019 –2030
  - Country Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
    - Brazil
    - Argentina
    - Mexico
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
    - Germany
    - U.K.
    - Spain
    - France
    - Italy
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030,(US$ Bn)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030,(US$ Bn)
    - South Africa
    - North Africa
    - Central Africa
Competitive Landscape
- Company Profile
- Novartis
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Merck
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Roche
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Amgen
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Pfizer
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Sun Pharma
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Bristol-Myers Squibb
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- AstraZeneca
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Johnson & Johnson
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Valeant
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Daiichi Sankyo
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Takeda Pharmaceutical
  - Company Limited
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- LEO Pharma
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Mylan N.V.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Sanofi
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Regeneron
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Eli Lilly
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Bayer
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Gilead Sciences
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Astellas Pharma
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Analyst Views
Section
- References
- Research Methodology
- About us

*Browse 25 market data tables and 29 figures on “Global Skin Cancer Drugs Market” - Global forecast to 2030

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request Discount